Topic: Influenza

Researchers Discover Possible New Target to Attack Flu Virus

April 9, 2014

[caption id="attachment_45357" align="alignright" width="300" caption="This region of the NS1 viral protein binds the host protein DDX21, making it a potential target for new antivirals against the flu virus"]NS1 Protein[/caption]

AUSTIN, Texas  Scientists at The University of Texas at Austin have discovered that a protein produced by the influenza A virus helps it outwit one of our body's natural defense mechanisms. That makes the protein a potentially good target for antiviral drugs directed against the influenza A virus.

Read more

Designer Bacteria May Lead to Better Vaccines

Jan. 15, 2013

Researchers at The University of Texas at Austin have developed a menu of 61 new strains of genetically engineered E. coli that may improve the efficacy of vaccines for diseases such as flu, pertussis, cholera and HPV.

Read more

Meet a Game Changer: Lauren Ancel Meyers

Jan. 23, 2012
Meet a Game Changer: Lauren Ancel Meyers

In this video, the mathematical epidemiologist reveals why she's so passionate about studying the spread and control of infectious diseases.

Read more

Discovery of Why Influenza B Virus Exclusively Infects Humans Opens Door for Drugs to Fight Seasonal Epidemics Caused by Virus

Aug. 26, 2011

The three-dimensional structure of a site on an influenza B virus protein that suppresses human defenses to infection has been determined by researchers at Rutgers University and The University of Texas at Austin.

Read more

Undergraduates study H1N1 at U.S.-Mexico border

April 15, 2010

Microbiology undergraduates Sami Miller and Kelly Broussard traveled to Brownsville to research tuberculosis alongside the world's foremost disease detectives, Joseph McCormick and Susan Fisher-Hoch.

Read more